Stay updated on Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new site revision tag was added (Revision: v3.4.2) and the previous revision tag (v3.4.1) along with a government funding operating-status notice were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about government funding and NIH operations has been added, and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a 'Show glossary' option and a new 'Revision: v3.4.0' notice, along with minor label updates such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedRemoved access to the Study Protocol and Statistical Analysis Plan PDF and other study documents. Additionally, related documentation references and MeSH terms were removed.SummaryDifference17%

- Check42 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3; no substantive changes to study details or page structure were detected based on the provided screenshots and text. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a consolidated Locations section with listed sites (Colorado, Missouri, Tennessee, Texas, Wisconsin) and removed the separate state location subsections. Revision updated from v3.3.2 to v3.3.3.SummaryDifference0.6%

Stay in the know with updates to Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial page.